WASHINGTON, D.C. — As the 2026 legislative calendar shifts into high gear, the advocacy arm of METAvivor,...
Metastatic Breast Cancer Research
By News Desk Editorial Staff As the metastatic breast cancer (MBC) community looks toward the horizon of...
As the first quarter of 2026 draws to a close, the METAvivor advocacy team has emerged from...
By the METAvivor Advocacy Team As the legislative session resumes following the April recess, the landscape for...
Main Facts: A Milestone in Research Funding In a significant development for the oncology community, the metastatic...
In the relentless pursuit of transforming metastatic breast cancer (MBC) from a terminal diagnosis into a manageable...
By METAvivor Advocacy Team As the legislative landscape in Washington D.C. shifts to meet the demands of...
As the first quarter of 2026 draws to a close, the advocacy team at METAvivor is navigating...
By [Your Name/Editorial Staff] In the landscape of modern oncology, the gap between clinical research and the...
Introduction: The Intersection of Advocacy and Science As the calendar year draws to a close, the non-profit...
